Influenza-B Tokio

Influenza-B Virus Tokio/53/99
Cat. No.
BT27841
Source
Synonyms
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Product Specs

Introduction
Influenza-B virus, a member of the Orthomyxoviridae family, infects only humans and seals, unlike Influenza A virus. It evolves slower than Influenza A but faster than Influenza C, mutating at a rate 2-3 times lower than type A. Its genome, comprising eight RNA segments, encodes for proteins like hemagglutinin and neuraminidase, essential for viral entry and release.
Description
This product contains purified Influenza B virus (strain B/Tokio/53/99) propagated in 10-day-old embryonated chicken eggs. The virus was purified from allantoic fluid using ultracentrifugation with a 10-40% sucrose gradient.
Inactivation
This product has been inactivated using Thimerosal and beta-propiolactone treatment. Despite inactivation, standard laboratory practices for handling microbiological/viral agents are required.
Physical Appearance
Sterile, colorless solution.
Formulation
The B/Tokio/53/99 solution contains 1.7mg/ml of the virus in STE buffer, with 0.1% sodium azide (NaN3) as a preservative and 0.005% thimerosal.
Stability
For optimal stability, store B/Tokio/53/99 below -18°C. While the product can be stored at 4°C for up to 4 weeks, repeated freezing and thawing should be avoided.
Purity
The purity of this product is greater than 90%, as determined by SDS-PAGE analysis.
Immunological Activity
Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA.

Product Science Overview

Introduction

Influenza B virus is a member of the Orthomyxoviridae family, which also includes Influenza A and C viruses. Unlike Influenza A, which infects a wide range of animals, Influenza B primarily infects humans and seals . The strain B/Tokio/53/99 is a specific variant of the Influenza B virus, which has been studied for its unique properties and behavior.

Structure and Composition

The Influenza B virus is an enveloped virus with a multipartite genome consisting of eight segments of linear negative-sense, single-stranded RNA . Each segment is encapsidated in a separate nucleocapsid, and the nucleocapsids are surrounded by an envelope. The virus has approximately 500 surface projections made of hemagglutinin and neuraminidase, which are crucial for the virus’s ability to infect host cells .

Genetic Characteristics

The genome of the Influenza B virus is 14,648 nucleotides long . It mutates at a rate 2-3 times lower than Influenza A, but still enough to prevent lasting immunity . This slower mutation rate means that Influenza B evolves more slowly than Influenza A but faster than Influenza C .

Purification and Formulation

The B/Tokio/53/99 strain is typically purified from the allantoic fluid of 10-day-old embryonated eggs inoculated with the virus . The purification process involves ultracentrifugation with a 10-40% sucrose gradient . The final product is a sterile, filtered colorless solution containing 0.1M NaCl, 10mM Tris HCl, 1mM EDTA (pH 8), 0.1% sodium azide, and 0.005% thimerosal .

Immunological Activity

The B/Tokio/53/99 strain is used in serological studies and as an immunogen for antibody production . It has been tested with anti-influenza B monoclonal antibodies in ELISA assays to confirm its immunological activity .

Storage and Stability

The B/Tokio/53/99 strain is stable at 4°C for up to four weeks but should be stored desiccated below -18°C for long-term storage . It is important to avoid freeze-thaw cycles to maintain its stability .

Safety Precautions

Both sodium azide and thimerosal, used in the formulation, are hazardous substances and should be handled by trained staff only . Proper laboratory practices and techniques are required to ensure safe handling and inactivation of the virus .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.